
Brand Name | Status | Last Update |
|---|---|---|
| pegasys | Biologic Licensing Application | 2025-08-11 |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hepatitis | D006505 | — | K75.9 | 4 | 17 | 33 | 58 | 37 | 148 |
| Hepatitis a | D006506 | EFO_0007305 | B15 | 4 | 17 | 32 | 58 | 37 | 147 |
| Chronic hepatitis c | D019698 | EFO_0004220 | B18.2 | 3 | 20 | 18 | 36 | 24 | 101 |
| Hepatitis c | D006526 | — | B19.2 | 2 | 11 | 22 | 38 | 24 | 97 |
| Chronic hepatitis b | D019694 | EFO_0004239 | B18.1 | 2 | 5 | 13 | 23 | 12 | 54 |
| Hepatitis b | D006509 | — | — | 2 | 5 | 13 | 22 | 13 | 53 |
| Chronic hepatitis | D006521 | — | K73.9 | — | 2 | 11 | 10 | 4 | 26 |
| Hiv infections | D015658 | EFO_0000764 | B20 | — | 5 | 7 | 1 | — | 12 |
| Coinfection | D060085 | — | — | — | — | 2 | 1 | 1 | 4 |
| Acquired immunodeficiency syndrome | D000163 | EFO_0000765 | B20 | — | 1 | — | 1 | 1 | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Renal cell carcinoma | D002292 | EFO_0000376 | — | — | 4 | 2 | — | 1 | 6 |
| Chronic hepatitis d | D019701 | — | — | — | 2 | 2 | — | 1 | 5 |
| Hepatitis d | D003699 | EFO_0007304 | — | — | 2 | 2 | — | 1 | 5 |
| Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | — | 2 | — | 3 | 5 |
| Infections | D007239 | EFO_0000544 | — | — | 2 | 2 | — | — | 4 |
| Essential thrombocythemia | D013920 | — | D47.3 | 1 | 1 | 1 | — | — | 3 |
| Polycythemia vera | D011087 | — | D45 | 1 | 1 | 1 | — | — | 3 |
| Thrombocytosis | D013922 | — | D75.83 | 1 | 1 | 1 | — | — | 3 |
| Polycythemia | D011086 | EFO_0005804 | D75.1 | 1 | 1 | 1 | — | — | 3 |
| Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | — | 1 | 3 | — | — | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Carcinoma | D002277 | — | C80.0 | — | 1 | — | — | — | 1 |
| Neoplasms | D009369 | — | C80 | — | 1 | — | — | — | 1 |
| Adenocarcinoma | D000230 | — | — | — | 1 | — | — | — | 1 |
| Margins of excision | D000072662 | — | — | — | 1 | — | — | — | 1 |
| Hepatocellular carcinoma | D006528 | — | C22.0 | — | 1 | — | — | — | 1 |
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | — | 1 | — | — | — | 1 |
| Communicable diseases | D003141 | — | — | — | 1 | — | — | — | 1 |
| Treatment failure | D017211 | — | — | — | 1 | — | — | — | 1 |
| Depression | D003863 | — | F33.9 | — | 1 | — | — | — | 1 |
| Major depressive disorder | D003865 | EFO_0003761 | F22 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hiv | D006678 | — | O98.7 | — | — | — | — | 1 | 1 |
| Insulin resistance | D007333 | EFO_0002614 | E88.819 | — | — | — | — | 1 | 1 |
| Hypertension | D006973 | EFO_0000537 | I10 | — | — | — | — | 1 | 1 |
| Portal hypertension | D006975 | EFO_0000666 | K76.6 | — | — | — | — | 1 | 1 |
| Drug common name | Peginterferon alfa-2a |
| INN | peginterferon alfa-2a |
| Description | Interferon alpha-2 precursor (Interferon alpha-A) (LeIF A) |
| Classification | Protein |
| Drug class | PEGylated compounds, covalent attachment of macrogol (polyethylene glycol) polymer |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | — |
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | CHEMBL1201560 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | DB00008 |
| UNII ID | Q46947FE7K (ChemIDplus, GSRS) |

